Ray, Arghya http://orcid.org/0000-0002-0652-2905
Du, Ting
Song, Yan http://orcid.org/0000-0002-6729-2672
Buhrlage, Sara J.
Chauhan, Dharminder http://orcid.org/0000-0002-5548-6138
Anderson, Kenneth C. http://orcid.org/0000-0002-6418-0886
Article History
Received: 6 August 2020
Revised: 27 November 2020
Accepted: 7 January 2021
First Online: 24 January 2021
Compliance with ethical standards
:
: KCA is on Advisory Boards of Millenium-Takeda, Gilead, Janssen, Sanofi-Aventis, and Bristol Myers Squibb; and is a Scientific Founder of Oncopep and C4 Therapeutics. DC is a consultant to Stemline Therapeutics, Inc., Oncopeptide AB, and an Equity owner in C4 Therapeutics. The remaining authors declare no conflict of interest. Other authors have no competing financial interests.